Yu, S., Yu, M., Keane, B., Mauro, D. M., Helft, P. R., Harris, W. P., . . . Somasundaram, A. (2024). A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma. The oncologist (Dayton, Ohio), 29(3), 270-e413. https://doi.org/10.1093/oncolo/oyad331
Citácia podle Chicago (17th ed.)Yu, Shawn, et al. "A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma." The Oncologist (Dayton, Ohio) 29, no. 3 (2024): 270-e413. https://doi.org/10.1093/oncolo/oyad331.
Citácia podľa MLA (8th ed.)Yu, Shawn, et al. "A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma." The Oncologist (Dayton, Ohio), vol. 29, no. 3, 2024, pp. 270-e413, https://doi.org/10.1093/oncolo/oyad331.